Use access key #2 to skip to page content.
$5.62 0.03 (0.54%)
12/3/2008 4:00 PM

Idenix Pharmaceuticals, Inc. (IDIX)

CAPS Rating:
*

A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe.

View All Commentary (IDIX)

Recs

0

Avatar RNZ100 (< 20) Submitted: 10/08/08 8:28 PM : Outperform Start Price: $5.11 IDIX Score: 22.32

Oversold (but then again, what isn't?!)

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links